Preview

Нефрология

Расширенный поиск

Исследования эффективности цитостатической терапии часто рецидивирующего, гормонозависимого и со стероидной токсичностью нефротического синдрома у детей

Полный текст:

Аннотация

В обзоре литературы обобщены имеющиеся данные контролируемых и ретроспективных исследований эффективности цитостатической терапии алкилирующими агентами, ингибиторами кальцинейрина и синтеза нуклеотидов часто рецидивирующего, гормонозависимого и со стероидной токсичностью нефротического синдрома у детей.

Об авторах

П. А. Ныркова
Санкт-Петербургский государственный педиатрический медицинский университет
Россия


Н. Д. Савенкова
Санкт-Петербургский государственный педиатрический медицинский университет
Россия


Список литературы

1. International Study of Kidney Disease in Children. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 1981; 98 (4): 561-564

2. APN Arbeitsgemeinschaft fur PadiatrischeNephrologie Short versus standart prednisolone therapy for initial treatment of idiopatic nephrotic syndrome in children. Lancet 1988;1: 380-383

3. Гринбаум Н.Б. Особенности нефротического синдрома у детей. В: Гломерулонефрит. Под ред. С.И. Рябова.- Л. 1980: 164-176 [Greenbaum NB. Osobennosti nefroticheskogo sindroma u detei'. V Glomerulonefrit. Pod red. S.I. Riabova.- L. 1980: 164-176]

4. Gbadegesin R, Smoyer W. Nephrotic Syndrome. In Comprehensive Pediatric Nephrology. Editors D. Geary, F. Schaefer. MOSBY 2008; 205-218

5. Hodson E, Alecsander S, and Graf N. Steroid-Sensitive Nephrotic Syndrome.In Comprehensive Pediatric Nephrology. Editors D.Geary, F. Schaefer. MOSBY 2008; 239-256

6. Arbeitsgemeinschaft fur PadiatrischeNephrologie: Minimal -change nephrotic syndrome (MCNS): long prednisone versus standard prednisone therapy (Abst) PediatrNephrol 1990; 4 :60

7. Niauted P. Steroid-Sensitive IdiopaticNephrotic Syndrome in Children.In Pediatric Nephrology. Editors E.Avner, W.Harmon, P.Niauted. LIPPINCOTT-WILLIAMS-WILKINS, 2004: 544-556

8. Niauted P, Boyer O. Idiopathic Nephrotic Syndrome in Children: Clinical Aspects. In Pediatric Nephrology, 6- th edition. Editors E. Avner, W.Harmon, N Yoshikawa.IPNA. Springer-Verlag, 2009; Vol.1:667-702

9. Brodehl J. Conventional therapy for idiopathic nephrotic syndrome in children. Clin. Nephrol1991; 35(1): 8-15

10. Савенкова Н.Д., Папаян А.В. Нефротический синдром в практике педиатра. С-Пб., Эскулап (1999): 256 [Savenkova ND, Papajan AV. Nefroticheskij sindrom v praktike pediatra. S-Pb., Jeskulap (1999): 256]

11. Батракова И.В., Савенкова Н.Д. Цитостатическая терапия нефротического синдрома с минимальными изменениями у детей. Нефрология 2004; 2:98-105 [Batrakova IV, Savenkova ND. Citostaticheskaja terapija nefroticheskogo sindroma s minimal’nymi izmenenijami u detej. Nefrologija 2004; 2:98-105]

12. Савенкова Н.Д., Папаян А.В., Батракова И.В. Нефротический синдром с минимальными изменениями у детей. В: Клиническая нефрология детского возраста. «Левша. Санкт-Петербург», 2008; 279-302 [Savenkova ND, Papajan AV, Batrakova IV. Nefroticheskij sindrom s minimal’nymi izmenenijami u detej. V Klinicheskaja nefrologija detskogo vozrasta. «Levsha. Sankt-Peterburg», 2008; 279-302]

13. Bargman JM. Management of minimal lesion glomerulonephritis Evidence-based recommendations. Kidney Int 1999; Suppl 70 (55): 3-16

14. Савенкова НД. Стратегия терапии дебюта, рецидивирующего и часто рецидивирующего гормоночувствительного и гормонозависимого нефротического синдрома с минимальными изменениями у детей. Нефрология 2013 №3: 17-25 [Savenkova ND. Strategija terapii debjuta, recidivirujushhego i chasto recidivirujushhego gormonochuvstvitel’nogo i gormonozavisimogo nefroticheskogo sindroma s minimal’nymi izmenenijami u detej. Nefrologija 2013 №3: 17-25]

15. Lombel RM, Hodson EM, Gipson DS. Treatment of steroid-resistant nephritic syndrome in children: new guidelines from KDIGO. Pediatr Nephrol2013 Mar;28(3):409-414

16. Clark A, Barratt TM. Steroid-responsive nephrotic syndrome. In Pediatric nephrology. Edited by ТМ. Barratt, E.D. Avner, WE Harman. LIPPINCOTT-WILLIAMS-WILKINS, 1998; 731-747

17. Pennisi AJ, Grushkin CM, Lieberman E. Cyclophosphamid in the treatment of idiopathic nephrotic syndrome. Pediatrics 1976; 57: 948-951

18. International Study of Kidney Disease in Children: Prospective, controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Lancet 1974; 2: 423-427

19. Arbeitsgemeinschaft fur Padiatrische Nephrologie: Cyclophosphamide treatment of steroid dependent nephrotic syndrome: Comparison of eight week with 12 week course. Arch Dis Child 1987; 62: 1102-1106

20. Ueda N, Kuno K, Ito S. Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. Arch Dis Child 1990; 85: 1147-1150

21. Ponticelli C, Edefonti A, Ghio L.Cyclosporin versus cyclophosphamide for patients with steroid dependent and frequently relapsing idiopathic nephrotic syndrome: a multicenter randomized controlled trial. Nephrol Dial Transplant 1993; 8: 1326-1332

22. Takeda A, Niimura F. Long-term effect of immunosuppressants in steroid-dependent nephrotic syndrome. PediatrNephrol 1998; 12 (9): 746-750

23. Kemper MJ, Altrogg H, Ludwig K et al. Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome. PediatrNephrol 2000; 14: 772-775

24. Vester U, Zimmermann S, Hoyer P. Cyclophosphamide therapy in frequent relapsing and steroid dependent minimal change nephrotic syndrome: new insights from an old protocol (abstract). PediatrNephrol 1999; 13: 67

25. Vester U, Kranz B, Zimmermann S, Hoyer P. Cyclophosphamide in frequently relapsing and steroid dependent nephrotic syndrome: Abstracts The 12 the Congress of the International Pediatric. NephrologyAssociationPediatrNephrol 2001; 16 (8): 258

26. Vester U, Kranz B. Cyclophosphamide in steroid-sensitive nephrotic syndrome outcome and outlook. PediatrNephrol. (2003) 18: 661-664

27. Kyrieleis HA, Levtcenko EN, Wetzels JF. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephritic syndrome.Am J Kidney Dis 2007; 49:592-597

28. Sümegi V, Haszon I, Bereczki C, Papp F, Tûri S. Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome. Pediatr Nephrol 2008 Jul;23(7):1085-1092

29. Chen SY Wu CY Tsai IJ, Tsau YK. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect. Nephrology (Carlton) 2010;15(3):336-339

30. Cammas B, Harambat J, Bertholet-Thomas A. et al. Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. Nephrol Dial Transplantant 2011; 26: 178-184

31. Zagury A, Louse A. et al. Long- term follow-up after cyclophosphamide therapy in steroid dependent nephrotic syndrome. Pediatr Nephro /2011; 26: 915-920

32. Azib S, Macher M, Kwon T et al. Cyclophosphamide in steroid dependent nephrotic syndrome. Pediatr Nephrol 2011; 26: 927-932

33. Grup W, Makker SP, Ingelfinger JR. Chlorambucil treatment of frequently relapsing nephrotic syndrome. N Engl J Med 1976; 295: 746-749

34. Niaudet P. Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology. PediatrNephrol 1992;6(1):1-3

35. Настаушева ТЛ, Ситникова ВП, Стеньшинская EB, Cтaxурлова ЛИ. Иммуносупрессивная терапия гломерулонефрита у детей цитостатическими препаратами алкилирующего действия. Нефрология и диализ 2000 2(4): 291-292 [Nastausheva TL, Sitnikova VP, Sten’shinskaja EB, Ctaxurlova LI. Immunosupressivnaja terapijaglomerulonefrita u detej citostaticheskimi preparatami alkilirujushhego dejstvija. Nefrologija i dializ 2000 2(4): 291-292]

36. Lewis MA, Baildom EM, Davis N, Houston IB, Postlethwaite RJ. Nephrotic syndrome: from toddlers to twenties. Lancet 1989 Feb 4;1(8632):255-259

37. Fakhouri F, Bocquet N, Taupin P. et al. Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis 2003 Mar;41(3):550-7

38. Rüth EM, Kemper MJ, Leumann EP. Et al. Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr 2005 Aug;147(2):202-7

39. Kyrieleis H, Löwik M, Pronk I. et al. Clin Long-Term Outcome of Biopsy-Proven, Frequently Relapsing Minimal-Change Nephrotic Syndrome in Children. J Am SocNephrol 2009; 4(10): 1593-1600

40. Kitano X Yoshikawa N, Tanaka R et al. Cyclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 1990; 4: 474-477

41. Tanaka Н, Yoshikava N, Kitano Y: Long-term Cyclosporin treatment in children with steroid dependent nephrotic syndrome. Pediatr Nephrol 1993; 7: 249-252

42. Ponticelli C, Edefonti A, Ghio L. et al. Cyclosporin versus cyclophosphamide for patients with steroid dependent and frequently relapsing idiopathic nephrotic syndrome: a multicenter randomized controlled trial. Nephrol Dial Transplant 1993; 8: 1326-1332

43. Hulton SA, Neuhaus TJ, Dillon MJ, Barrat TM. Long-term cyclosporine A treatment of minimal-change nephrotic syndrome of children. Pediatr Nephrol 1994; 8: 401-403

44. Inou X Iijima K, Nakamura H, Yoshikava N: Two-year Cyclosporin treatment in children with steroid dependent nephrotic syndrome. Pediatr Nephrol 1999; 13: 33-38

45. Игнатова МС, Турпитко ОЮ, Харина ЕА, Обухова ВА. Результаты многоцентрового изучения эффективности циклоспорина А при нефротическом синдроме у детей. Педиатрия 2008; 87:93-97 [Ignatova MS, Turpitko OJu, Harina EA, Obuhova VA. Rezul’taty mnogocentrovogo izuchenija jeffektivnosti ciklosporina A pri nefroticheskom sindrome u detej. Pediatrija 2008; 87:93-97]

46. Dorresteijn EM, Kist-van Holthe JE, Levtchenko EN, Nauta J, Hop WC, van der Heijden AJ. Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome. Pediatr Nephrol 2008; 23(11):2013-2020

47. Wang W, Xia XMao J. et al. Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome. Pediatr Nephrol 2012; 27: 2073-2079

48. Tejani A, Butt K,TrechtmanH. Cyclosporin A induced remission of frequently relapsing nephrotic syndrome in children. Kidney Int1988; 33:729-734

49. Iijima K, Hamahira K, Tanaka R. et al. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int 2002; 61(5):1801-1805

50. Rinaldi S, Sesto A, Barsotti P et al. Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome. Pediatr Nephrol 2005; 20: 25-29

51. Matsumoto H, Hakao T, Okada T et al. Initial remission inducing effect of very low-olosecyclosporin monotherapy for minimal-change nephrotic syndrome in Japannese adults. Clin. Nephrol2001; 55(2): 143-148

52. Fujinaga S, Kaneko K, Muto T. et al. Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome. Arch Dis Child 2006; 91(8):666-670

53. Igarashi Y et al. Steroid-sparing effect of mizoribine in long-term nephrotic syndrome of children. PediatrNephrol 1994; 8: 396-397

54. Yoshioka K, Ohashi X Sacai T et al. A multicenter trial of mizoribine compared with placebo in children in frequently relapsing idiopathic nephrotic syndrome. Kidney Int 2000; 58: 317-324

55. Fujieda M, Ishihara M, Morita T. et al. Effect of oral mizoribine pulse therapy for frequently relapsing steroid-dependent nephrotic syndrome. ClinNephrol 2008; 69(3):179-184

56. Fujieda M, Ishihara M, Morita T. et al. Effect of singledose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome. Clin Nephrol 2012;78(1):40-46

57. Fujinaga S, Hirano D, Nishizaki N. Single daily high-dose mizoribine therapy for children with steroid-dependent nephritic syndrome prior to cyclosporine administration. Pediatr Nephrol 2011; 26: 479-483

58. Kawasaki X Takano K, Isome M et al. Efficacy of single dose of oral mizoribine pulse therapy two times per week for frequently relapsing nephritic syndrome. J Nephrol 2007 20:52-56

59. Hogg R, Fizgibbons L, Bruick J et al. Multicenter trial of mycophenolate mofetil (MMF) in children with steroid dependent (SD) or frequently relapsing (FR) nephrotic syndrome (NS). Report of the southwest pediatric nephrology study group. Abstract book from the World Congress of Nephrology.June 8-12, Berlin (2003). Nephrol Dial Transplant 2003; 18 (Suppl. 4): 261

60. Barletta GM, Smoyer WE, BunchmannTE et al. Use of mycophenolate mofetil in steroid-dependent and-resistant nephrotic syndrome. Pediatr Nephrol 2003; 18:833-837

61. Vallejo GG, Liern MM, De Reyes VV et al. Enteric Coated Mycophenolate Sodium in Patients with steroid-dependent nephrotic syndrome. Congress Abstracts the 15th Congress of the International Pediatric Nephrology Association. August 29- September, 2010, New York. Pediatr Nephrol 2010; 25:1886

62. Bagga A, Hari P, Moudgil A, Jordan SC: Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephritic syndrome. Am J Kidney Dis 2003;42: 1114-1120

63. Novak L, Frank R, Vento S et al. Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol 2005; 20(9) 1265-1268

64. Mendizabal S, Zamona I, Berbel O et al. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome. Pediatr Nephrol 2005; 20(7):914-919

65. Kwinta-Rybicka J, Wilkosz K, Wierchowska-Slowiacze EK et al. Mycophenolate mofetil in treatment of childhood nephrotic syndrome -preliminary report. Przegl Lec 2006;63 Suppl 3:44-48

66. Fujinaga S, Ohtomo X Umino D. et al. A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome. Pediatr Nephrol 2007; 22: 71-76

67. Afzal K, Bagga A, Menon S et al. Treatment with mycophenolatemofetil and prednisolone for steroid-dependent nephritic syndrome. Pediatr Nephrol 2007; 22: 2059-2065

68. Nickavar A, Safarzadeh AE, Sotoudeh K et al. Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome in children. Iran J Kidney Dis 2012; 6(5):346-349

69. Baudouin V, Albrti C, Lapeyraque AL et al. Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial. Pediatr Nephrol 2012;27(3):389-396

70. Banerjee S, Pahari A, Sengupta J, Patnaik S. Outcome of severe steroid-dependent nephrotic syndrome treated with mycophenolate mofetil. Pediatr Nephrol 2013; 28:93-97

71. Gellermann J, Weber L, Pape L. et al. Mycofenolate Mofetil versus Cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol 2013; 24(10):1689-1697

72. Lombel RM, Gipson DS, Hodson EM. Treatment of steroidsensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol 2013 Mar;28(3):415-426


Для цитирования:


Ныркова П.А., Савенкова Н.Д. Исследования эффективности цитостатической терапии часто рецидивирующего, гормонозависимого и со стероидной токсичностью нефротического синдрома у детей. Нефрология. 2015;19(1):30-40.

For citation:


Nyrkova P.A., Savenkova N.D. Studies of cytostatic therapy efficiency for frequently relapsing steroid dependent nephrotic syndrome with steroid toxicity in children. Nephrology (Saint-Petersburg). 2015;19(1):30-40. (In Russ.)

Просмотров: 121


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)